LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.0056667
 37.71 27.76 1711 2877 0.5946 0.8506
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 39.41 27.76 1742 3105 0.5609 0.8371
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 39.41 27.76 1770 3105 0.5699 0.8414
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 39.41 27.76 177 3105 0.0570 0.3129
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 39.41 27.76 1752 3105 0.5641 0.8387
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 41.11 27.76 1752 3331 0.5259 0.8223
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 41.11 27.76 1780 3331 0.5343 0.8265
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 41.11 27.76 206 3331 0.0618 0.3367
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 41.11 27.76 1832 3331 0.5499 0.8341
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 42.81 27.76 1853 3596 0.5153 0.8197
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 42.81 27.76 1882 3596 0.5233 0.8237
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 42.81 27.76 231 3596 0.0642 0.3525
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 42.81 27.76 1921 3596 0.5342 0.8290
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 44.52 27.76 1976 3884 0.5087 0.8191
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 44.52 27.76 2002 3884 0.5154 0.8224
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 44.52 27.76 253 3884 0.0651 0.3634
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 44.52 27.76 1985 3884 0.5110 0.8203
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 46.22 27.76 2085 4125 0.5055 0.8195
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 46.22 27.76 2108 4125 0.5110 0.8223
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 46.22 27.76 275 4125 0.0667 0.3741
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 46.22 27.76 2117 4125 0.5132 0.8234
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 47.93 27.76 2161 4421 0.4888 0.8136
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 47.93 27.76 2181 4421 0.4933 0.8158
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 47.93 27.76 323 4421 0.0731 0.3986
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 47.93 27.76 2182 4421 0.4935 0.8160
MN20160318_Q01
N13